Login / Signup

Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.

Ji Won MinHyeyoung LeeBum Soon ChoiCheol Whee ParkChul Woo YangYong Soo KimYeong Jin ChoiEun Jee OhByung Ha Chung
Published in: Annals of laboratory medicine (2018)
Pre-transplant anti-AT1R is an important risk factor for allograft failure, which may be mediated by MVI induction in the allograft tissue.
Keyphrases
  • angiotensin ii
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • angiotensin converting enzyme
  • patient reported outcomes
  • binding protein